| 1.628 -0.004 (-0.25%) 12-15 17:29 |
|
| Open: | 1.642 |
| High: | 1.650 |
| Low: | 1.610 |
| Pre. close: | 1.632 |
| Volume: | 114,848 |
| Avg. volume: | 278,608 |
| MA (50): | 1.702 |
| MA (200): | 1.769 |
| Year high: | 2.500 |
| Year low: | 1.330 |
| Market cap: | 150(M) |
| EPS: | -0.55 |
| PE ratio: | -2.96 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Thu, 11 Dec 2025
Innate Pharma Announces 2026 Financial Calendar - TipRanks
Thu, 11 Dec 2025
Innate Pharma Releases Its 2026 Financial Calendar - Yahoo Finance
Fri, 28 Nov 2025
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025 - Business Wire
Thu, 13 Nov 2025
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results - Business Wire
Mon, 10 Nov 2025
Innate Pharma stock soars after FDA clears path for Phase 3 trial - Investing.com
Mon, 10 Nov 2025
Innate Pharma Receives FDA Clearance for Phase 3 Lacutamab Trial - TipRanks
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.